ALX ONCOLOGY HOLDINGS INC (ALXO) Stock Price, Quote, News and Overview
NASDAQ:ALXO - Nasdaq - US00166B1052 - Common Stock - Currency: USD
ALXO Quote, Performance and Key Statistics
ALX ONCOLOGY HOLDINGS INC
NASDAQ:ALXO (1/23/2025, 8:42:47 PM)
After market: 1.6201 -0.01 (-0.61%)1.63
-0.17 (-9.44%)
The current stock price of ALXO is 1.63 USD. In the past month the price increased by 0.62%. In the past year, price decreased by -88.94%.
ALXO Latest News, Press Releases and Analysis
Which stocks are gapping on Thursday?
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer
Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to show substantial tumor response...
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings, Inc. (“ALX Oncology” or the “Company”), (Nasdaq: ALXO), a...
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
/PRNewswire/ -- USA News Group News Commentary – Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January...
ALXO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.88 | 301.60B | ||
| AMGN | AMGEN INC | 14.46 | 149.37B | ||
| GILD | GILEAD SCIENCES INC | 20.98 | 115.80B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 862.22 | 113.24B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.29 | 76.33B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.00B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.54B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.43B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.66B | ||
| NTRA | NATERA INC | N/A | 22.68B | ||
| BIIB | BIOGEN INC | 8.8 | 20.94B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.18B |
Related screens
About ALXO
Company Profile
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. The company is headquartered in South San Francisco, California and currently employs 89 full-time employees. The company went IPO on 2020-07-17. Its product candidate, evorpacept, is a CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. The company is engaged in focusing on combining evorpacept with anti-cancer antibodies, ADCs, and PD-1/PD-L1 immune checkpoint inhibitors. Cancer cells leverage CD47, a cell surface protein, as a don’t eat me signal to evade macrophage phagocytosis or as a don't activate T-cells signal that prevents activation of T-cells by dendritic cells. The company focuses on combining evorpacept with anti-cancer antibodies, ADCs, and PD-1/PD-L1 immune checkpoint inhibitors. The company also has a preclinical program focused on developing ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer.
Company Info
ALX ONCOLOGY HOLDINGS INC
323 Allerton Avenue
South San Francisco CALIFORNIA 94010 US
CEO: Jaume Pons
Employees: 81
Company Website: https://alxoncology.com/
Investor Relations: https://ir.alxoncology.com/
Phone: 16504667125
ALXO FAQ
What is the price of ALXO?
The current price of ALXO is 1.63 USD.
What is the symbol for ALX ONCOLOGY HOLDINGS INC?
The exchange symbol of ALX ONCOLOGY HOLDINGS INC is ALXO and it is listed on the Nasdaq exchange.
On which exchange is ALXO listed?
ALXO is listed on the Nasdaq exchange.
Is ALXO a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ALXO, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ALXO.
Does ALXO pay dividends?
ALXO does not pay a dividend.
What is the Price/Earnings (PE) ratio of ALXO?
ALXO does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.98).
What is the Short Interest ratio of ALXO?
The outstanding short interest for ALXO is 18.11% of its float.
ALXO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ALXO. When comparing the yearly performance of all stocks, ALXO is a bad performer in the overall market: 93.86% of all stocks are doing better.
ALXO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALXO. Both the profitability and financial health of ALXO have multiple concerns.
ALXO Financial Highlights
Over the last trailing twelve months ALXO reported a non-GAAP Earnings per Share(EPS) of -2.98. The EPS increased by 16.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -81.39% | ||
| ROE | -110.49% | ||
| Debt/Equity | 0.09 |
ALXO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 77% to ALXO. The Buy consensus is the average rating of analysts ratings from 13 analysts.